The win at Bathurst is just the latest of many for Audi and its privateer-run R8 LMS race cars, marking the 119th time the car has claimed victory since it was introduced three years ago.

The deal – worth up to $380 million – comes as BMS is preparing to further the rollout of its CAR-Ts Abecma (idecabtagene vicleucel) and Breyanzi (lisocabtagene maraleucel), used to treat ...